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Introduction {#sec1}
============

The human gastrointestinal pathogens enteropathogenic *Escherichia coli* (EPEC) and enterohemorrhagic *E. coli* (EHEC) colonize the gut mucosa while forming attaching and effacing (A/E) lesions, which are characterized by the effacement of the brush border microvilli and intimate bacterial attachment to the apical surface of intestinal epithelial cells (IECs) ([@bib17]). Intimate attachment is mediated by the binding of intimin, a bacterial outer membrane adhesin, to the translocated intimin receptor (Tir), which is delivered into mammalian cells via a type III secretion system (T3SS) injectisome ([@bib27]). The T3SS is encoded by four operons, i.e., locus for enterocyte effacement (LEE) 1--4, and the monocistronic *escD* gene within the LEE pathogenicity island ([@bib38], [@bib14]), and translocates multiple LEE-encoded (e.g., Tir, Map, EspG) and non-LEE- encoded (e.g., EspJ, NleA-F, TccP) effectors that manipulate signaling in the host cell ([@bib65], [@bib42], [@bib53]). Expression of the T3SS and effector genes can be induced by growing EPEC/EHEC in low-glucose DMEM (DMEM priming) *in vitro* ([@bib47], [@bib1], [@bib18]).

The clustering of Tir~EPEC~ by intimin induces the phosphorylation of Tyr474 in the C terminus of Tir by redundant non-receptor tyrosine kinases (e.g., Src, ABL) ([@bib65], [@bib42]). The Src homology domain 2- and 3- (SH2 and SH3) containing adaptor NCK interacts with phosphorylated tyrosine residues in Tir and recruits N-WASP (neural Wiskott-Aldrich syndrome protein), which activates the ARP2/3 (actin-related protein-2/3) complex leading to the formation of actin-rich pedestal-like structures at sites of bacterial attachment. Although Tir is conserved in all A/E pathogens, ARP2/3 activation and actin polymerization by Tir~EHEC~ (e.g., O157:H7) requires TccP (Tir-cytoskeleton coupling protein) ([@bib21], [@bib6]), which is recruited by IRTKS (insulin receptor tyrosine kinase substrate) or IRSp53 (insulin receptor substrate p53) adaptors via their interaction with the conserved NPY motif in Tir ([@bib59], [@bib61], [@bib31]). TccP structurally mimics the autoinhibitory element within N-WASP, leading to ARP2/3-dependent phosphotyrosine-independent actin polymerization ([@bib16]). The physiological role of Tir-induced actin polymerization is poorly understood.

Macrophages can promote host defense by sensing and responding to infection via inflammasomes, which are signaling platforms that activate caspase-1 ([@bib12], [@bib5]). A/E pathogen-associated molecules, including lipopolysaccharides (LPS), nucleic acids, and T3SS inner rod and needle proteins, can activate caspase-1 via the NOD leucine-rich repeat proteins (NLRs) and the adaptor protein ASC ([@bib46], [@bib23], [@bib58], [@bib72], [@bib67], [@bib24]). The activation of caspase-1 in macrophages leads to the proteolytic maturation of pro-interleukin (IL)-1β and pro-IL-18 and pyroptosis through the proteolysis of gasdermin-D (GSDMD) ([@bib5]), which together promote immunity against infection ([@bib35], [@bib40], [@bib55]).

NLRP3 (NOD, leucine-rich repeat and Pyrin domain-containing protein 3) inflammasome assembly is stimulated by the loss of cytosolic K^+^, which can occur via two broadly distinct mechanisms. Canonical NLRP3 activation involves K^+^ efflux by the opening of P2X7 channels by its ligand ATP or bacterial ionophore toxins (e.g., nigericin) ([@bib5]). The non-canonical NLRP3 pathway involves the activation of caspase-11 in mouse cells and caspase-4 or caspase-5 in human cells by cytosolic LPS, which leads to the cleavage of GSDMD, efflux of K^+^, and pyroptosis ([@bib25]). LPS sensing also leads to pro-IL-1β and pro-IL-18 processing via caspase-1 activation by the NLRP3-ASC inflammasome ([@bib25], [@bib54]). Moreover, activation of caspase-11 by LPS can lead to the cleavage of pannexin-1 channels, resulting in pyroptosis and the release of ATP, which can also activate NLRP3 ([@bib68]).

EHEC and the mouse A/E pathogen *Citrobacter rodentium* grown without DMEM priming (i.e., bacteria poorly expressing the virulence regulon) stimulate inflammasomes similarly to non-pathogenic *E. coli* K12, resulting in non-canonical NLRP3 activation in mouse macrophages at 10--18 h post-infection ([@bib46], [@bib22], [@bib58]). This is also similar to the pathway induced by direct delivery of LPS into the cytosol (e.g., by transfection). Whether EPEC infection activates the inflammasome in human macrophages and the impact of virulence genes on this pathway is presently unknown.

In this study, we investigated inflammasome activation in primary human monocyte-derived macrophages (MDMs) infected with EPEC expressing the virulence regulon. We found an essential role for caspase-4 in rapid caspase-1 activation via NLRP3 in response to virulent EPEC. Tir-mediated actin polymerization was indispensable for inflammasome activation in a manner that markedly differed from that induced by the transfection of cytosolic LPS. Our findings establish a crosstalk between caspase-4 and caspase-1 during natural infection by virulent EPEC.

Results {#sec2}
=======

EPEC Induces T3SS-Dependent Activation of NLRP3 in Human Macrophages {#sec2.1}
--------------------------------------------------------------------

We investigated whether DMEM-primed EPEC activated the inflammasome in primary human CD14^+^ MDMs and phorbol 12-myristate 13-acetate (PMA)-differentiated THP1 cells by measuring pyroptotic cell death (release of lactate dehydrogenase \[LDH\]), uptake of propidium iodide (PI) dye, and immunoblots for caspase-1 and its substrates. Cells infected at a multiplicity of infection (MOI) of 10 for 4--5 h underwent pyroptotic death within 4 h of infection in a T3SS-dependent manner ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). Immunoblots confirmed the presence of active caspase-1 p20 and proteolytic processing of pro-IL-18 upon infection with wild-type (WT) EPEC but not the T3SS-deficient Δ*escF* mutant ([Figure 1](#fig1){ref-type="fig"}A). To test whether NLRP3 was required for EPEC-induced caspase-1 activation, we used the NLRP3-specific inhibitor MCC950 ([@bib8], [@bib20]). This revealed that MCC950 treatment blocked EPEC-induced LDH release (∼85% reduction), caspase-1 activation, and reduced GSDMD proteolysis ([Figures 1](#fig1){ref-type="fig"}B, 1C, and [S1](#mmc1){ref-type="supplementary-material"}B). MCC950 also inhibited LPS plus ATP-mediated caspase-1 activation as a positive control of canonical NLRP3 activation ([Figure S1](#mmc1){ref-type="supplementary-material"}C).Figure 1EPEC Induces Rapid, NLRP3-Dependent Pyroptosis and Cytokine Processing in Human Monocyte-Derived Macrophages and THP1 Cells(A) Primary human monocyte-derived macrophage (MDMs) were infected with DMEM-primed wild-type (WT) or T3SS-deficient Δ*escF* EPEC for 4 h. Pyroptosis measured by lactate dehydrogenase (LDH) release (n = 6 independent repeats from four donors) is plotted on top in (A) and representative immunoblots for indicated proteins are shown below.(B and C) Primary MDMs were left uninfected (UI) or infected with WT EPEC without or with MCC950 (5 μM). LDH release assay (B) and representative immunoblots (C) are shown (n = 5 independent repeats from four donors).(D--F) THP1 cells were left UI or infected with DMEM-primed indicated strains of EPEC (WT or T3SS-deficient Δ*escF*) for 4 h (D and F) or up to 5 h (E). The graph in (E) shows real-time propidium iodide (PI) uptake (means ± SEMs; n = 3 independent experiments). MCC950 was used at 5 μM. ^∗∗^p \< 0.01, ^∗∗∗∗^p \< 0.0001 by two-way ANOVA with false discovery rate (FDR)-based correction for multiple comparisons.The matching shapes and colors of symbols in graphs in (A) and (B) denote data from independent donors and/or experiments. Immunoblots (A, C, D, and F) are representative of experiments performed at least three times. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 by two-tailed paired Student's t test.

Like primary MDMs, PMA-differentiated THP1 cells also underwent T3SS-dependent rapid pyroptosis as observed by real-time PI uptake and immunoblots, which showed the proteolysis of caspase-1, the pyroptosis-associated substrate GSDMD, and pro-IL-1β and pro-IL-18 cytokine precursors ([Figures 1](#fig1){ref-type="fig"}D, [S1](#mmc1){ref-type="supplementary-material"}D, and S1E). Moreover, the treatment of THP1 cells with MCC950 also blocked pyroptosis and caspase-1 activation by EPEC ([Figures 1](#fig1){ref-type="fig"}E, 1F, and [S1](#mmc1){ref-type="supplementary-material"}F). As expected, pyroptosis induced by LPS transfection, as a positive control for non-canonical caspase-4-dependent pyroptosis, was not inhibited by MCC950 ([Figure S1](#mmc1){ref-type="supplementary-material"}G). We therefore concluded that EPEC activates rapid cytokine processing and pyroptosis via the NLRP3-caspase-1 inflammasome in primary MDMs and THP1 macrophages in a T3SS-dependent manner.

NLRP3-Caspase-1 Activation via Caspase-4 Drives EPEC-Induced Pyroptosis {#sec2.2}
-----------------------------------------------------------------------

To obtain independent support for the involvement of NLRP3-ASC-caspase-1 and pyroptosis in EPEC-induced cell death, we used RNAi. Stable silencing of *GSDMD* or *ASC* (THP1^GSDMDmiR^ or THP1^ASCmiR^ cells) attenuated pyroptosis induced by EPEC as measured by PI uptake and LDH release assays ([Figures 2](#fig2){ref-type="fig"}A, [S2](#mmc1){ref-type="supplementary-material"}A, and S2B). As a control, we verified that LPS transfection of these cells triggered ASC-independent and GSDMD-dependent pyroptosis and ASC- and GSDMD-dependent proteolytic processing of caspase-1 ([Figures 2](#fig2){ref-type="fig"}B, 2C, and [S2](#mmc1){ref-type="supplementary-material"}C). In agreement with MCC950 treatment, EPEC-induced proteolysis of GSDMD was blocked by the silencing of ASC, further pointing toward a role for caspase-1 in the process ([Figure 2](#fig2){ref-type="fig"}D). In agreement with these findings, silencing *CASP1* expression reduced pyroptosis and GSDMD cleavage in response to EPEC infection ([Figures S2](#mmc1){ref-type="supplementary-material"}D and S2E). These results indicated that the NLRP3-ASC-caspase-1 inflammasome plays a major role in GSDMD processing and pyroptosis during EPEC infection.Figure 2EPEC-Induced Caspase-1 Activation, Cytokine Processing, and Pyroptosis Requires Caspase-4 and GSDMD(A and B) Real-time PI-uptake assays from THP1 cells stably expressing non-targeting (*CTRL*) or miRNA30E against the indicated genes. THP1 cells were infected with EPEC for indicated times (A) or transfected with LPS using lipofectamine 2000 (B). Means ± SEMs from n = 3 independent experiments are shown. ^∗∗∗∗^p \< 0.0001 by two-way ANOVA with FDR-based correction for multiple comparisons for indicated comparisons between *CTRL*^*miR*^ and others.(C--E) Representative immunoblots from THP1 cells stably expressing non-targeting (*CTRL*) or miRNA30E against the indicated genes transfected with LPS for 4 h (C) or infected with EPEC for 4 h (D and E). Pooled supernatants and lysates were used for immunoblots. Schematics in (C) and (E) show caspase-4-dependent inflammasome signaling by transfected LPS and EPEC, respectively.Data in (C)--(E) are representative of experiments performed at least three times.

Because caspase-4 is involved in sensing Gram-negative pathogens such as *Salmonella, Legionella*, and *Francisella* in primary human MDMs ([@bib7], [@bib30]), we next examined its involvement upstream of the NLRP3-ASC-caspase-1 inflammasome during EPEC infection (see schematics in [Figures 2](#fig2){ref-type="fig"}C and 2E). Stable silencing of caspase-4 (THP1^CASP4miR^) markedly attenuated pyroptosis ([Figures 2](#fig2){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}B) and caspase-1 activation ([Figure 2](#fig2){ref-type="fig"}E). Independent validation was obtained with small interfering RNA (siRNA) against caspase-4, which showed it was required for pyroptosis and IL-1β release as measured by ELISA from EPEC-infected macrophages ([Figure 3](#fig3){ref-type="fig"}A); as expected, caspase-4 was required for pyroptosis induced by cytosolic LPS, but not during treatment with LPS plus nigericin ([Figures S2](#mmc1){ref-type="supplementary-material"}F and S2G). *CASP4* silencing in primary MDMs also decreased pyroptosis and IL-1β release upon EPEC infection and LPS transfection ([Figure 3](#fig3){ref-type="fig"}B). *CASP8* silencing had no impact on EPEC-induced pyroptosis ([Figure S2](#mmc1){ref-type="supplementary-material"}H). Mechanistically, GSDMD and pannexin-1 have been implicated in the non-canonical activation of caspase-1 (schematic in [Figure 2](#fig2){ref-type="fig"}C) ([@bib25], [@bib68]). We found that GSDMD silencing, but not the inhibition of pannexin-1 channels, abrogated pyroptosis and caspase-1 activation in response to EPEC infection ([Figures 2](#fig2){ref-type="fig"}A, 2D, and [S2](#mmc1){ref-type="supplementary-material"}I). Consistent with a temporally early role of caspase-4 in EPEC-induced pyroptosis, immunoblots showed caspase-4 activation in cell lysates within 1 h of infection, whereas cleaved caspase-1 and GSDMD proteins were detected at 3 and 5 h post-infection ([Figure S2](#mmc1){ref-type="supplementary-material"}J). These results revealed a surprising role for GSDMD and caspase-4 upstream of cytokine processing and pyroptosis induced by caspase-1 during EPEC infection.Figure 3EPEC Induces Caspase-4- and Caspase-1-Dependent Pyroptosis and Cytokine Processing in Human Macrophages(A) Quantification of pyroptosis by LDH release assay and IL-1β by ELISA from THP1 cells transfected with non-targeting (*CTRL*) or the indicated siRNA and infected with EPEC for 4 h. Representative immunoblots for silencing of caspase-4 and ASC are shown at right. Graphs show LDH release (means ± SEMs from n = 5 independent experiments) and IL-1β release by ELISA (means ± SDs from n = 2 experiments). ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 by one-way ANOVA.(B) Pyroptosis as measured by LDH release and IL-1β quantification by ELISA from primary MDMs transfected with *CTRL* or *CASP4* siRNA and then infected with EPEC or transfected with LPS as labeled. Matching shapes and colors of symbols in graphs represent n = 3 independent donors. ^∗^p \< 0.05 by two-tailed Student's t test.

Non-pathogenic *E. coli* and lysogeny broth (LB)-grown EHEC activate late caspase-4-dependent pyroptosis in mouse macrophages ([@bib25], [@bib46], [@bib58]). We found that infection by LB-grown EPEC caused weaker and delayed inflammasome activation in primary MDMs and THP1 cells, which markedly contrasted DMEM-primed bacteria ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3D). Mechanistically, pyroptosis induced by LB-grown EPEC was kinetically delayed, independent of the T3SS, ASC independent, and GSDMD dependent ([Figure S3](#mmc1){ref-type="supplementary-material"}E). In particular, DMEM-primed bacteria induced ∼5-fold higher pyroptosis than LB-grown bacteria at 5 h post-infection. Furthermore, LB-grown WT and Δ*escF* induced comparable levels of pyroptosis at 5 and 18 h post-infection ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3D). These results suggested that DMEM priming of EPEC not only accelerated pyroptosis but also altered the inflammasome signaling mechanisms that drive pyroptosis in host cells. We concluded that EPEC expressing virulence genes upregulated by DMEM priming (e.g., the LEE and non-LEE regulons) provoked rapid atypical inflammasome signaling, in which caspase-4 mediated NLRP3-caspase-1 activation, but did not directly induce pyroptosis on its own.

LPS Sensing by Caspase-4 Promotes EPEC-Induced Inflammasome Activation {#sec2.3}
----------------------------------------------------------------------

LPS from intracellular cytosolic and/or vacuolar Gram-negative pathogens are a potent activator of caspase-4. We therefore investigated whether reduced pyroptosis upon infection with Δ*escF* was due to its reduced internalization or cytosolic escape as compared to WT EPEC. To this end, we performed antibiotic-protection assays using gentamicin- (which kills extracellular bacteria) and chloroquine- (which kills vacuolar bacteria) protection assays ([@bib28], [@bib56]) in THP1^GSDMDmiR^ cells, which do not lyse during infection. This revealed similar numbers of intracellular WT and Δ*escF* EPEC, most of which were vacuolar, and only ∼2.5%--5% were cytosolic ([Figure S3](#mmc1){ref-type="supplementary-material"}F). These findings suggested that the differential internalization or vacuolar escape was not responsible for the difference in pyroptosis induced by WT and Δ*escF* strains.

While human caspase-4 is activated by the direct binding of LPS in the caspase activation and recruitment domain (CARD), the LPS-binding site in mouse caspase-11 is better defined, and the mutation of three positively charged (lysine) residues in the CARD to glutamate (Cas11^KE^) abrogates LPS binding and non-canonical inflammasome activation ([@bib54]). We reconstituted THP1^CASP4miR^ cells with mouse caspase-11, the LPS-binding mutant (Cas11^KE^) or the catalytically inactive mutant (Cas11^CM^) ([Figure S3](#mmc1){ref-type="supplementary-material"}G). In agreement with previous reports, LPS transfection confirmed that mouse caspase-11, but not Cas11^KE^ or Cas11^CM^, can substitute for human caspase-4 in this setting ([Figure S3](#mmc1){ref-type="supplementary-material"}H) ([@bib54]). Similarly, the expression of caspase-11, but not Cas11^KE^ or Cas11^CM^, also restored rapid pyroptosis in THP1^CASP4miR^ cells infected with EPEC ([Figure S3](#mmc1){ref-type="supplementary-material"}I). These results suggested that EPEC induces T3SS-, LPS-, and caspase-4-dependent inflammasome activation in human macrophages that requires caspase-1 for both pyroptosis and cytokine processing.

Tir Is Essential for Inflammasome Activation by EPEC {#sec2.4}
----------------------------------------------------

We investigated which T3SS effector or effectors were required for inflammasome activation. Consistent with the roles of NleA/EspI ([@bib69]) and NleF ([@bib41]) in suppressing inflammasome responses, pyroptosis induced by the ΔPP6 strain (which lacks NleA/EspI, NleF, NleH, and EspO) was higher as compared to WT EPEC ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Deletion of other non-LEE pathogenicity islands did not markedly affect pyroptosis in THP1 cells (data not shown), leading us to assess effectors encoded within the LEE. We particularly focused on Tir, which is the dominant LEE-encoded effector. Deletion of Tir attenuated pyroptosis and the proteolysis of GSDMD, caspase-1, pro-IL-1β, and pro-IL-18 in primary MDMs ([Figures 4](#fig4){ref-type="fig"}A and 4B) and THP1 cells ([Figures 4](#fig4){ref-type="fig"}C, [S4](#mmc1){ref-type="supplementary-material"}B, and S4C). Immunofluorescence microscopy of THP1^ASC-mRFP^ cells infected with EPEC revealed severely reduced ASC inflammasome foci formation by the Δ*escF* and Δ*tir* strains ([Figures 4](#fig4){ref-type="fig"}D and 4E). As expected, actin-rich pedestals were not observed upon the deletion of *escF* or *tir* ([Figure S4](#mmc1){ref-type="supplementary-material"}D). Actin polymerization and inflammasome activation were restored upon complementation of the Δ*tir* strain by ectopic expression of Tir from an isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside (IPTG)-inducible promoter (pTir; [Figures 4](#fig4){ref-type="fig"}A--4E and [S4](#mmc1){ref-type="supplementary-material"}E). Furthermore, higher Tir abundance, induced by increasing IPTG concentrations, correlated with elevated pyroptosis ([Figure 4](#fig4){ref-type="fig"}F) and proteolysis of caspase-1 ([Figure S4](#mmc1){ref-type="supplementary-material"}E).Figure 4Tir Is Essential for EPEC-Induced Pyroptosis and Cytokine Processing(A and B) LDH release assays (A) and representative immunoblots (B) from primary human MDMs infected with the indicated EPEC strains for 4 h. IPTG (0.1 mM) was used to induce the expression of pTir. Graph in (A) is from n = 5 independent experiments from four donors. Cell lysates were used for β-actin detection and supernatants for caspase-1, caspase-4, and IL-18.(C) Quantification of cell lysis (LDH release assay) from THP1 cells infected with the indicated EPEC strains for 4 h (n = 5 independent experiments).(D) Representative images from immunofluorescence microscopy of THP1^ASC-mRFP^ cells (red) with the indicated EPEC strains stained with antibody against EPEC (green) and Hoechst nuclear dye (blue) showing re-localization of ASC into foci (arrowheads). Scale bar, 20 μm.(E) Quantification of ASC specks in experiments described in (D) from n = 3--5 independent experiments.(F) THP1 cells were infected for 4 h with Δ*tir* EPEC expressing Tir from an IPTG-inducible plasmid (pTir). Bacteria were treated with the indicated concentrations of IPTG for 30 min before infection. LDH release (n = 3 experiments) and representative immunoblots (bottom) for Tir and DnaK are shown.(G) LDH release assay from THP1 cells infected for 4 h with MOI 10 of synthetic injector *E. coli* (SIEC) strains or WT or Δ*tir* EPEC, as indicated. SIEC strains were treated with IPTG for 30 min before infection to induce the expression of LEE operons (n = 5 independent experiments).The matching shapes and colors of the symbols in the graphs in (A), (C), and (E)--(G) denote data from independent donors and/or experiments. Immunoblots represent two to three independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗∗^p \< 0.0001 by one-way ANOVA.

We next investigated whether Tir alone was necessary and sufficient for inflammasome activation. To this end, we used the synthetic injector *E. coli* K12 (SIEC) strain, which contains chromosomally integrated T3SS genes under IPTG-inducible promoters ([@bib49]). The SIEC with engineered LEE5 (SIECeLEE5), which additionally expresses Tir, its chaperone CesT, and intimin, efficiently translocates Tir and triggers intimin-dependent actin pedestals ([@bib49]). Similar to WT EPEC, infection of THP1 cells with SIECeLEE5 induced rapid pyroptosis, which was markedly diminished in the absence of eLEE5 (SIEC strain) or the lack of a functional T3SS due to the deletion of the promoter of LEE1 (SIECΔp1) ([Figure 4](#fig4){ref-type="fig"}G). Pyroptosis induced by IPTG-treated SIEC bacteria (∼20% ± 10%; [Figure 4](#fig4){ref-type="fig"}G) was comparable to SIECΔp1 (∼8% ± 4%; [Figure 4](#fig4){ref-type="fig"}G), which ruled out a major role for NLRC4 (NOD, leucine-rich repeat and CARD-containing protein 4) inflammasomes that detect flagellin and T3SS structural proteins. EPEC flagellin and needle (EscF) and rod (EscI) proteins are poor NLRC4 inflammasome activators in human macrophages ([@bib67], [@bib72]). Furthermore, similarly to EPEC, IPTG-treated SIECeLEE5 stimulated atypical pyroptosis in a caspase-4 and ASC-dependent manner ([Figure S4](#mmc1){ref-type="supplementary-material"}F). These experiments suggested that intimin and Tir were necessary and sufficient for atypical inflammasome activation in human macrophages.

Tir-Induced Actin Polymerization Is Required for Inflammasome Activation {#sec2.5}
------------------------------------------------------------------------

To test the hypothesis that signaling induced downstream of Tir clustering by its ligand intimin was required for inflammasome activation, we infected macrophages with EPEC expressing Tir Y474A/Y454A (Tir^AA^, which neither undergoes phosphorylation nor activates N-WASP) ([@bib66]) or the Δ*eae* mutant (which cannot activate Tir as it lacks intimin) ([@bib37]) (schematic in [Figures 5](#fig5){ref-type="fig"}A and [S5](#mmc1){ref-type="supplementary-material"}A). Supporting our hypothesis, EPEC expressing Tir^AA^ and the Δ*eae* strain induced little pyroptosis or inflammasome activation in primary MDMs (∼77% reduction; [Figures 5](#fig5){ref-type="fig"}B and 5C). Pyroptosis by these strains was similarly attenuated in THP1 cells (∼75% reduction; [Figures 5](#fig5){ref-type="fig"}D, 5E, and [S5](#mmc1){ref-type="supplementary-material"}B), even though both strains were internalized to levels that are similar to those in WT bacteria ([Figure S3](#mmc1){ref-type="supplementary-material"}F). Treatment with cytochalasin D, which inhibits actin polymerization, impaired pyroptosis induced by EPEC; LPS transfection-induced pyroptosis was not affected by cytochalasin D and served as a negative control ([Figures S5](#mmc1){ref-type="supplementary-material"}C and S5D). In addition, an EPEC strain overexpressing the ADP-ribosyltransferase EspJ, which inactivates non-receptor tyrosine kinases and suppresses Tir signaling ([@bib44], [@bib70]), also induced less pyroptosis ([Figure S5](#mmc1){ref-type="supplementary-material"}E). These findings pointed to an essential role for Tir-driven actin polymerization in inflammasome activation.Figure 5EPEC and EHEC Tir-Dependent Actin Polymerization Drives Pyroptosis and Cytokine Processing(A) Schematic showing the genetically distinct mechanisms of N-WASP and ARP2/3-dependent actin polymerization induced by Tir proteins from EPEC or EHEC upon clustering by their ligand intimin.(B and C) Cell lysis (LDH release) assays (B) and representative immunoblots (C) of primary human MDMs infected with the indicated strains of EPEC for 4 h (n = 4 independent experiments from four donors).(D) Cell lysis of THP1 cells infected with the indicated strains of EPEC for 4 h (n = 4 independent experiments).(E) Representative immunoblots from THP1 cells infected with the indicated strains of EPEC for 4 h. The intervening irrelevant lanes were removed, and images from the same immunoblot for each antibody are shown for groups of strains as labeled.(F and G) Cell lysis assays (F) and representative immunoblots (G) from THP1 cells infected with the indicated strains of EPEC expressing Tir from EPEC or EHEC, or additionally expressing EHEC TccP (n = 5 independent experiments).The matching shapes and colors of the symbols in the graphs in (B), (D), and (F) denote data from independent donors and/or experiments. Immunoblots are representative of experiments performed at least two times. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, and ^∗∗∗∗^p \< 0.0001 by one-way ANOVA.

Unlike EPEC, EHEC triggers the formation of actin-rich pedestals by translocating Tir and TccP (schematic in [Figure 5](#fig5){ref-type="fig"}A) ([@bib21], [@bib6]). Complementing the EPEC Δ*tir* mutant with a plasmid encoding Tir~EHEC~ could not restore actin polymerization due to the absence of TccP in EPEC ([Figure S5](#mmc1){ref-type="supplementary-material"}F). The EPECΔ*tir*^+^Tir~EHEC~ strain also failed to activate inflammasomes ([Figures 5](#fig5){ref-type="fig"}F and 5G). In contrast, co-expression of Tir~EHEC~ and TccP in EPECΔ*tir* fully restored actin polymerization and inflammasome activation as quantified by pyroptosis assays and immunoblot analyses of caspase-1 and pro-IL-1β ([Figures 5](#fig5){ref-type="fig"}F, 5G, and [S5](#mmc1){ref-type="supplementary-material"}F). Tir-driven actin polymerization, rather than Tir translocation alone or other effectors, is involved in rapid atypical non-canonical inflammasome activation in human macrophages.

Discussion {#sec3}
==========

In this study, we have shown that the infection of human macrophages with EPEC triggers an atypical caspase-4-dependent NLRP3 signaling pathway, which is distinct from that stimulated by LPS transfection or infection by non-pathogenic *E. coli*, and requires signaling downstream of the effector Tir delivered by the pathogen into host cells. Recent studies on inflammasome signaling in human myeloid cells have uncovered surprisingly broad roles for NLRP3, for example, in the detection of cytosolic DNA, which contrasts its roles in mouse macrophages ([@bib20]). Similarly, differences have been reported between human and mouse NLRC4 signaling pathways ([@bib71], [@bib19]). Our studies on primary human MDMs support a role for NLRP3 in detecting EPEC infection, which we demonstrate is also conserved in THP1 cells. Atypical signaling (schematic in [Figure 2](#fig2){ref-type="fig"}E) involved the combined roles of caspase-4 and GSDMD in promoting NLRP3 activation, and pyroptotic cell death required the activities of both caspase-1 and caspase-4. The NLRP3-ASC-caspase-1 inflammasome rapidly processed cytokines and GSDMD following infection by virulent EPEC.

Structural studies on the gasdermin family member GSDMA3 have uncovered a soluble pre-pore complex containing oligomers of the caspase-cleaved N-terminal fragment, which undergoes maturation upon membrane insertion ([@bib48]). Cleaved GSDMD may similarly require additional signals for membrane insertion and eventually causing cell death. Therefore, as yet unknown processes in addition to proteolytic cleavage may be required for GSDMD-mediated pyroptosis. Moreover, GSDMD pores on cell membranes can be repaired by the endosomal sorting complexes required for transport (ESCRT) machinery, including those caused by *Salmonella* infection ([@bib50]). Future studies should investigate the additional roles of caspase-1/-4 in GSDMD maturation and pyroptosis during EPEC infection in human macrophages.

On the pathogen side, inflammasome activation by EPEC was dependent on the detection of bacterial LPS and Tir-intimin-induced actin polymerization. Bacterial internalization or cytosolic escape did not correlate with macrophage survival as strains that were markedly defective in inducing pyroptosis; Δ*escF*, the strain expressing TirAA, and Δ*eae* were phagocytosed similarly to WT EPEC. Furthermore, a synthetic *E. coli* K12 strain expressing intimin, the T3SS, and Tir was fully competent in stimulating atypical pyroptosis. These findings indicated two things: (1) T3SS effectors other than Tir (and its chaperone) are not required for triggering pyroptosis and (2) activation of caspase-4 by LPS was independent of the O antigen as *E. coli* K12 expresses rough LPS.

The indispensable roles for caspase-4 and NLRP3 in detecting EPEC in MDMs adds to the diverse Gram-negative bacteria sensed by human caspase-4, including *Francisella, Legionella*, and *Yersinia* ([@bib7], [@bib30]). These studies also found differential roles of caspase-4 in detecting natural infection by bacteria versus transfected LPS. In our study, too, atypical NLRP3 activation by natural infection of MDMs by EPEC differed from caspase-4-signaling upon LPS transfection. Unlike in *Salmonella* ([@bib36]) and *Yersinia* ([@bib43], [@bib62]), caspase-8 was dispensable for EPEC-induced macrophage cell death.

Macrophage pyroptosis strictly relied on the expression of the EPEC LEE virulence regulon, which not only accelerated caspase-4-dependent inflammasome activation but also led to atypical pyroptosis. It is possible that actin polymerization by Tir-intimin signaling promotes rapid LPS internalization for caspase-4 activation. Mouse caspase-11, which can localize to sites of bacterial infection ([@bib56]), binds to actin regulatory proteins AIP1 (also called WDR1; [@bib33]) and Flightless I ([@bib34]). It is possible that EPEC-induced changes to cortical actin affect local caspase-4/-11 activity. Access of cleaved GSDMD to the plasma membrane at sites of bacterial attachment may also be limited, which may be why EPEC-induced pyroptosis required the cooperative activities of caspase-4 and caspase-1 for optimal GSDMD cleavage.

A/E pathogens typically secrete 25--30 effectors, which subvert various host processes, including opsonophagocytosis, activation of nuclear factor κB (NF-κB), mitogen-activated protein kinases (MAPKs), type I interferons, and cell death ([@bib42], [@bib53]). NleB, NleC, NleD, and NleE, which block NF-κB and MAPKs, may also attenuate signaling by IL-1/IL-18 cytokines produced by robust Tir-dependent inflammasome activation. We showed that NleF inhibited caspase-4 in human and mouse IECs ([@bib41]). As NLRP3 expression in IECs is low, caspase-4 contributes to pro-IL-18 conversion into mature IL-18 ([@bib29], [@bib41]). Neutrophil influx into the colonic mucosa driven by IL-18 *in vivo* was suppressed in an NleF-dependent manner ([@bib41]). However, in macrophages, only the combined deletion of NleF and NleA/EspI (and NleH and EspO as with the ΔPP6 mutant) increased EPEC-induced pyroptosis. We reason that a higher abundance of caspase-4 and NLRP3 in macrophages may reduce the inhibitory effects of individual EPEC effectors.

Tir-dependent actin polymerization is genetically distinct in EPEC and EHEC. Our findings suggested that Tir-proximal events were relatively less important as compared to changes in actin dynamics. Some EPEC strains can use both NCK-dependent and TccP/EspFU-dependent pathways for actin polymerization ([@bib63], [@bib16]). Whether such strains trigger heightened inflammatory responses via inflammasomes should be investigated. Alterations to actin dynamics are used by the host as a pathogen-sensing mechanism; for example, *Burkholderia* TecA ([@bib2]) and *Salmonella* SopE ([@bib26]) are detected by PYRIN and NOD1, respectively. Whether caspase-4/-11 could also serve as a guardian of the host cytoskeleton during infection by Gram-negative bacteria will need further study ([@bib39]). In summary, our study establishes an essential role for Tir-intimin-dependent actin polymerization in rapid inflammasome activation in human macrophages and has important implications for host defense against EPEC infection.

STAR★Methods {#sec4}
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Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Monoclonal Anti-beta-Actin-Peroxidase antibody produced in mouseSigma-AldrichCat\# A3854 RRID:[AB_262011](nif-antibody:AB_262011){#intref0010}Caspase-4 (4B9) antibodySanta Cruz BiotechnologyCat\# sc-56056, RRID:[AB_781828](nif-antibody:AB_781828){#intref0015}Mouse Anti-Human GSDMDC1 Monoclonal Antibody, Unconjugated, Clone 64-YSanta Cruz BiotechnologyCat\# sc-81868, RRID:[AB_2263768](nif-antibody:AB_2263768){#intref0020}Rabbit anti-human GSDMD antibody (L60)Cell Signaling TechnologyCat\# 96458SCleaved Caspase-1 (D7F10) Rabbit AntibodyCell Signaling TechnologyCat\# 3866S RRID:[AB_2069051](nif-antibody:AB_2069051){#intref0025}anti-Caspase-1 (p20) (human) mAb (Bally-1) antibodyAdipoGenCat\# AG-20B-0048, RRID:[AB_2490257](nif-antibody:AB_2490257){#intref0030}Human IL-18 Polyclonal AntibodyMBL InternationalCat\# PM014, RRID:[AB_592017](nif-antibody:AB_592017){#intref0035}Goat Anti-Human Il-1 beta / il-1f2 Polyclonal antibody, UnconjugatedR and D SystemsCat\# AF-201-NA, RRID:[AB_354387](nif-antibody:AB_354387){#intref0040}anti-Asc pAb (AL177) antibodyAdipoGenCat\# AG-25B-0006, RRID:[AB_2490440](nif-antibody:AB_2490440){#intref0045}Rat Anti-Human Caspase-11 Monoclonal Antibody, PE Conjugated, Clone 17D9Thermo Fisher ScientificCat\# 12-9935-82, RRID:[AB_1518784](nif-antibody:AB_1518784){#intref0050}Tir CT[@bib3]N/ADnaK (*E. coli*), mAb (8E2/2) antibodyEnzo Life SciencesCat\# ADI-SPA-880, RRID:[AB_10619012](nif-antibody:AB_10619012){#intref0055}Anti-α0127:H6R. La RagioneN/AAnti-WASL antibody produced in rabbitSigma-AldrichCat\# HPA005750, RRID:[AB_1854729](nif-antibody:AB_1854729){#intref0060}Donkey Anti-Rabbit IgG, Whole Ab ECL Antibody, HRP ConjugatedGE HealthcareCat\# NA934, RRID:[AB_772206](nif-antibody:AB_772206){#intref0065}Sheep Anti-Mouse IgG, Whole Ab ECL Antibody, HRP ConjugatedGE HealthcareCat\# NA931, RRID:[AB_772210](nif-antibody:AB_772210){#intref0070}Donkey anti-goat IgG-HRP Polyclonal, Hrp Conjugated antibodySanta Cruz BiotechnologyCat\# sc-2056, RRID:[AB_631730](nif-antibody:AB_631730){#intref0075}Donkey anti-Goat IgG (H+L) Secondary Antibody, HRPThermo Fisher ScientificCat\# A15999, RRID:[AB_2534673](nif-antibody:AB_2534673){#intref0080}Cy3-AffiniPure Fab Fragment Donkey Anti-Rabbit IgG (H+L) antibodyJackson ImmunoResearch LabsCat\# 711-167-003, RRID:[AB_2340606](nif-antibody:AB_2340606){#intref0085}DyLight 488 AffiniPure Donkey anti Rabbit IgG (H+L) antibodyJackson ImmunoResearch LabsCat\# 711-485-152, RRID:[AB_2492289](nif-antibody:AB_2492289){#intref0090}Alexa Fluor 488 AffiniPure Donkey Anti-Chicken IgY (IgG) (H+L) antibodyJackson ImmunoResearch LabsCat\# 703-545-155, RRID:[AB_2340375](nif-antibody:AB_2340375){#intref0095}Alexa Fluor 647 donkey anti-mouse antibodyJackson ImmunoResearch LabsCat\# 715-606-151, RRID:[AB_2340866](nif-antibody:AB_2340866){#intref0100}Alexa Fluor® 594 Phalloidin antibodyThermo Fisher ScientificCat\# A12381, RRID:[AB_2315633](nif-antibody:AB_2315633){#intref0105}Alexa Fluor® 647 Phalloidin antibodyThermo Fisher ScientificCat\# A22287, RRID:[AB_2620155](nif-antibody:AB_2620155){#intref0110}**Chemicals, Peptides, and Recombinant Proteins**LPS-EB (LPS from *E. coli* O111:B4)InvivogenCat\# tlrl-3pelpsATPSigma-AldrichCat\# A2383ChloroquineSigma-AlrdichCat\# C6628NigericinSigma-AldrichCat\# N7143Cytochalasin DSigma-AldrichCat\# C8273Isopropyl β-D-1-thiogalactopyranoside (IPTG)Sigma-AldrichCat\# \#I6758KanamycinSigma-AldrichCat\# 60615AmpicillinSigma-AldrichCat\# A9518ChloramphenicolSigma-AldrichCat\# C0378Puromycin dihydrochloride from *Streptomyces alboniger*Sigma-AldrichCat\# P8833GentamicinSigma-AldrichCat \# G1272Propidium iodide (PI)Sigma-AldrichCat \# P4170MCC950Tocris BioscienceCat \# 5479ProbenecidSigma-AldrichCat\# P8761-25GLipofectamine 2000 Transfection ReagentLife TechnologiesCat\# 11668027DMSOSigmaCat\# D2438-50MLcOmplete protease inhibitor cocktailRocheCat\# 04693116001Pierce Phosphatase Inhibitor Mini TabletsThermo Fisher ScientificCat\# A32957Pierce Protease Inhibitor Mini Tablets, EDTA-freeThermo Fisher ScientificCat\# A32955Clarity Western ECL Blotting substrateBio-Rad LaboratoriesCat\# 1705061ECL Prime Western Blotting Detection ReagentGE-HealthcareCat\# RPN2236DAPI for nucleic acid stainingSigma-AldrichCat\# D9542Hoechst 33342 dyeThermo Fisher ScientificCat\# H1399ProLong Gold Antifade MountantThermo Fisher ScientificCat\# P36930Phenylmethanesulfonyl fluorideSigma-AldrichCat\# P7626Phorbol myristate acetate (PMA)Sigma-AldrichCat\# P8139HEPES solutionSigma-AldrichCat\# H0887Trypsin-EDTASigma-AldrichCat\# T4049Dulbecco's minimal Eagle media Low Glucose (1000mg/L)Sigma-AldrichCat\# D6046Dulbecco's minimal Eagle media High Glucose (4500mg/L)Sigma-AldrichCat\# D5796RPMI 1640Sigma-AldrichCat\# R8758RPMI 1640 -- Phenol Red FreeGIBCOCat\# 11835030Fetal Bovine SerumSigma-AldrichCat\# F9665Sodium pyruvateSigma-AldrichCat\# S8636Penicillin-StreptomycinSigma-AldrichCat\# P4333Opti-MEMGIBCOCat \# 31985062L-Glutamin SolutionSigmaCat \# G7513CD14-BiotinMiltenyi BiotecCat\# 130-190-485Anti-Biotin MicrobeadsMiltenyi BiotecCat\# 130-190-485LS ColumnsMiltenyi BiotecCat\# 130-042-401LeucoSep Centrifuge TubesGreiner Bio-OneCat\# 227288**Critical Commercial Kits**CytoTox 96® Non-Radioactive Cytotoxicity AssayPromegaCat\# G1780Human Il-1 beta/Il-1F2 DuoSetR and D SystemsCat\# DY201Viromer BlueLipocalyxCat\# VB-01LB-00**Biological Samples**Healthy CD14 positive monocyte-derived macrophagesNHS Blood and Transplant, Colindale London, NW9 5BGN/A**Experimental Models: Bacterial Strains**Stbl2 *E. coli*[@bib57]N/AEPEC E2348/69[@bib32]N/AΔ*escF* E2348/69[@bib64]ICC171Δ*tir* E2348/69[@bib4]ICC255Δ*eae* E2348/69[@bib37]ICC257E2348/69 ΔPP6::CmFRT (*nleF -- nleH2 -- nleA/espI*)This StudyN/AE2348/69 ΔPP2::Km315 (*nleH1 -- espJ --cif^∗^*)This StudyN/AE2348/69 ΔIE2::CmFRT (*nleE2 -- nleB3 -- espL*)[@bib60]ICC1062E2348/69 ΔIE6::Km315 (*espL-- nleB1-- nleE*)[@bib60]ICC1060E2348/69 ΔPP4::CmFRT (*nleI/nleG- nleB2 --nleC -- nleD*)[@bib60]ICC240E2348/69 Tir~Y454A/Y474A~[@bib66]ICC311E2348/69 Tir~Y454A~[@bib66]ICC309E2348/69 Tir~Y474A~[@bib66]ICC310SIEC[@bib49]ICC1337SIEC-LEE5[@bib49]ICC1338siEC ΔpLEE1-LEE5[@bib49]ICC1339**Experimental Model: Cell Lines**THP-1John MacMicking laboratory ([@bib52])N/AHEK293EJohn MacMicking laboratory ([@bib52])N/AHEK293TManoj Krishnan laboratory ([@bib45])N/A**Plasmids**pMX-CMV-YFP-CTRL^miR^ (LacZ) 5′-TCACGACGTTGT\
AATACGACGT-^3′^[@bib13]N/ApMX-CMV-YFP-GSDMD^miR^\
^5′^-TACACATTCATTGAGGTGCTGG-^3′^[@bib13]N/ApMX-CMV-YFP-CASP4^miR^\
5′-ATATCTTGTCATGGACAGTCGT-^3′^[@bib41]N/ApMX-CMV-YFP-ASC^miR^\
^5′^-CAGCTCTTCAGTTTCACACCAG-^3′^This studyN/ApMX-mAsc-mRFPThis studyN/ApLX-mCas11-CASP4^miR^This studyN/ApLX-mCas11KE-CASP4^miR^This studyCys254AlapLX-mCas11CM-CASP4^miR^This studyLys62Glu,Lys63Glu,Lys64GlupSA10-TccP[@bib21]pICC281pSA10-EspJ[@bib70]pICC1618pACYC-TirEHEC[@bib11]pEH86pSA10-TirEPEC[@bib66]pICC394pKD46[@bib10]ori101, *repA* 101 (ts), *araBp-gam-bet-exo, blaM*pKD3[@bib10]oriRγ, *blaM*, Cm^R^ cassette flanked by FRT sitespSB315[@bib9]Source of *aphT* cassette (Kn^R^)**Oligonucleotides**^5′^ATGCTATCACCATCTTCTGTAAATTTGGGGTG\
TTCATGGAATTCTTTAACcacgttgtgtctcaaaatctc^3′^This study (for generating E2348/69 ΔPP2::Km315)orf530 FRTKan315^5′^ATGCCAATCATAAAGAACTGCTTATCATCAATT\
AGTAACATATTACGCAAgaattccccggatccgtcgac^3′^This study (for generating E2348/69 ΔPP2::Km315)EspJ EPEC Kan315 rev^5′^ATGAAGCTCATTCTTGCGACGCGTAATTATTATCTGG\
AATATGGTTTGCGGTGTAGGCTGGAGCTGCTTCG^3′^This study (for generating E2348/69 ΔPP6::CmFRTOrf294 EPEC FRT^5′^CATCCACATTGTAAAGATCCTTTGTTGTAAGTAAGAT\
CTGGTACCCTAATAATACATATGAATATCCTCCTTAG^3′^This study (for generating E2348/69 ΔPP6::CmFRTZ6020FRTrev**Software and Algorithms**Bio-Rad Image LabBio-Rad<http://www.bio-rad.com/en-uk/product/image-lab-software?ID=KRE6P5E8Z>Zen BlueCarl Zeiss<https://www.zeiss.com/microscopy/int/products/microscope-software/zen.html>Fiji™NIH<https://imagej.nih.gov/ij/>GraphPad Prism 7.0GraphPad Software<https://www.graphpad.com/scientific-software/prism/>

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by Avinash Shenoy (<a.shenoy@imperial.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Ethics statement {#sec4.3.1}

For human MDM experiments, cells were isolated from screened blood obtained from anonymous adult male and female donors to the NHS Blood and Transplant, Colindale, London. Experiments were performed in compliance and approval from the Imperial College Healthcare Tissue Bank.

### Preparation of primary monocyte derived macrophages (MDMs) {#sec4.3.2}

Leukocytes cones from anonymous healthy platelet donors to the NHSBT were used. CD14+ cells were enriched by MACS (Magnetic-activated Cell Sorting, Miltenyi Biotec) from buffy coats prepared using 50 mL LeucoSep tubes (Greiner Bio-One). Briefly, 10 mL blood from a single donor was mixed with 50 mL pre-warmed PBS, and 30 mL was processed per LeucoSep tube. The buffy coat layer obtained by centrifugation (1000 *x*g, 20 min at room temperature on a swing-out rotor) was separated and cells washed three times with 20 mL of pre-warmed RPMI and two times with 20 mL of MACS buffer (50 mg/ml BSA, 2 mM EDTA in PBS). CD14+ cells were enriched using biotinylated anti-CD14+ antibody and anti-biotin microbeads following the manufacture's protocol (Miltenyi Biotec). Enriched cells (∼85%--95% CD14+ by flow cytometry) were cultured for 7 days in RPMI containing 1 mM sodium pyruvate, 10% heat inactivated fetal bovine serum (FBS), 100 μg/ml penicillin and 100 μg/ml streptomycin, 10 mM HEPES (pH 7.5) (complete RPMI) plus 20 ng/ml human M-CSF to allow differentiation into macrophages. Media was replenished every 72 h and antibiotics and M-CSF were withdrawn 24 h before experiments.

### Bacterial Strains {#sec4.3.3}

Bacterial strains used in this study are listed in the [Key Resources Table](#sec4.1){ref-type="sec"}. All EPEC mutants are derivatives of EPEC serotype O127:H6 strain E2348/69 ([@bib32]). Bacteria were routinely grown in lysogeny broth (LB) with appropriate antibiotics where necessary (kanamycin (100 μg/ml); chloramphenicol (25 μg/ml); ampicillin (100 μg/ml)) in a shaking incubator at 37°C for ∼18 h. When used for infection, these are indicated as LB-grown bacteria in Text and [Figure S2](#mmc1){ref-type="supplementary-material"}. Unless otherwise indicated DMEM-primed EPEC, which have elevated expression of the LEE/non-LEE virulence regulon, were prepared for macrophage infections as follows: overnight LB-grown cultures were diluted 1:50 into low-glucose (1000 mg/L) Dulbecco's minimal Eagle media (DMEM) and grown statically for 3 h at 37°C in a humidified incubator with 5% CO~2~. When required, isopropyl thio-galactopyranoside (IPTG) for pSA10 plasmid-encoded effector expression was added 30 min prior to use (i.e., at 2.5 h post-inoculation into DMEM). SIEC strains are derivatives of *E. coli* K-12 (MG1655Δ*fimA-H*) ([@bib49]), and were grown overnight in LB and diluted 1:50 into fresh LB and grown statically for 3 h at 37°C in a humidified incubator with 5% CO~2.~ Protein expression in SIEC strains and from pSA10-plasmids was induced with IPTG (0.1 mM) 30 min prior to infection.

### Mammalian Cell Culture {#sec4.3.4}

THP1 cells were cultured in suspension in complete RPMI 1640 and seeded on glass coverslips in 24-well plates (density 6x10^5^cells/well) for immunofluorescence, 48-well plates (4x10^5^cells/well) for western blotting or 96-well black-wall clear-bottom plates (density 1.5x10^5^cells/well) for cell death assays. Cells were differentiated with 100 ng/mL phorbol 12-myristate 13-acetate (PMA) and for 48 h and PMA withdrawn for 24 h before experimental treatments. HEK293 cells were maintained as sub-confluent monolayers in high-glucose (4500 mg/L) DMEM plus penicillin and streptomycin, sodium pyruvate and 10% heat-inactivated FBS. Retro- or Lenti- viral plasmid-transduced cell lines were cultured with puromycin (2 μg/ml). All cell lines were maintained at 37°C and 5% CO~2~, and were tested to be mycoplasma-negative (LookOut Mycoplasma PCR Detection Kit, Sigma). Cell lines were validated by short tandem repeat (STR) profiling (Microsynth AG, Switzerland).

Method Details {#sec4.4}
--------------

### Cell Treatments and *in vitro* infection {#sec4.4.1}

Naive MDMs or PMA-differentiated naive THP1 were used for bacterial infections i.e., without priming with TLR agonists. Macrophages were infected with bacteria at a multiplicity of infection (MOI) of 10 (verified by viable counts), and infections synchronized by centrifuged for 10 min at 750 *x*g. Gentamicin (200 μg/ml) was added 2 h post-infection and incubation continued for 4 h or as indicated in the Figure Legends. Inhibitors were added 1 h before treatment or infection at the following concentrations: Probenecid (100 μM), MCC950 (5 μM). For canonical NLRP3 activation, cells were primed with ultrapure O111:B4 LPS (250 ng/mL) for 3 h followed by nigericin (20 μM) treatment for 45 min or ATP (5 mM) for 60 min. For non-canonical inflammasome activation, cells were left unprimed and transfected for 4 h with LPS (5 μg/mL) using Lipofectamine 2000 (1% v/w). For immunoblot analyses, cells were washed three times with serum-free RPMI and bacterial infections or treatments were carried out in OptiMEM containing 1 mM sodium pyruvate ([@bib13]).

### Generation of bacterial strains {#sec4.4.2}

Strains and plasmids are listed in the [Key Resources Table](#sec4.1){ref-type="sec"}. Mutants are derivates of EPEC O127:H7 strain E2348/69 and were generated using the λ Red recombinase method ([@bib10]) using primers listed in the [Key Resources Table](#sec4.1){ref-type="sec"} and pKD3 (Cm^R^) or pSB315 (Kn^R^) plasmids as template.

### Immunoblotting {#sec4.4.3}

For immunoblot analyses of proteins in supernatants, proteins were precipitated at −20°C overnight in acetone, air-dried and resuspended in 2X Laemmli loading buffer plus 5% 2ME ([@bib13]). Cell extracts were prepared in ice-cold RIPA buffer (60 mM Tris pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% Na-deoxycholate, 1 mM EDTA; all from Sigma) supplemented with complete protease inhibitor tablets, and 1 mM phenylmethylsulfonyl fluoride (PMSF), followed by the addition of 5% 2ME and Laemmli loading buffer([@bib51]). Pooled culture supernatants and cell extracts were prepared by resuspending air-dried precipitates of supernatants in cell lysates prepared from respective samples. SDS-PAGE used Tris-Glycine buffers and proteins were transferred to PVDF membranes using a TransBlot semi-dry electrophoretic transfer machine (Bio-Rad). Membranes were blocked for 2 h at room temperature in 10% fat-free milk and incubated overnight (at 4°C) with antibodies as indicated in the [Key Resources Table](#sec4.1){ref-type="sec"}. Immunoblots were developed with Clarity Western (Bio-Rad) ECL or ECL Prime (GE).

### LDH Assays {#sec4.4.4}

Loss of cell membrane integrity was measured by quantifying lactate dehydrogenase (LDH) activity in culture supernatants using the CytoTox 96 nonradioactive cytotoxicity assay kit following manufacturer's protocol. Briefly, absorbance at 490 nm was measured, and expressed as percentage of that of uninfected/untreated cells treated with 1% Triton X-100 ([@bib13]).

### PI time-course assay {#sec4.4.5}

Cells were cultured in complete RPMI media without phenol red, and EPEC cultures were primed in DMEM media without phenol red to minimize background fluorescence. Immediately prior to infection, each well was supplemented with 5 μg/mL propidium iodide (PI), and fluorescence was measured every 10 min on a POLARStar Omega plate reader (BMG Labtech). Experimental values were calculated as relative percentage of uninfected cells treated with 0.05% Triton X-100 ([@bib13]).

### siRNA transfections {#sec4.4.6}

ON-Target Plus SMARTpool (Dhamacon) small interfering RNA (siRNA) were used to transiently knockdown *CASP4*, *ASC* and *CASP8* in MDMs and THP1 cells (see [Table S1](#mmc1){ref-type="supplementary-material"}). THP1 cells were plated in 96-well plates at a density of 8 × 10^4^ cells/well to achieve 70% confluency and transfected with siRNA using the Viromer Blue (VB) transfection reagent following the manufacturer's protocol for suspension cells. Cells were incubated in suspension for 6 h post-transfection, then differentiated using 100 ng/ml PMA and used for experiments at 72 h post-transfection. Medium was replaced with fresh medium without PMA 24 h before experiments. MDMs were transfected with siRNA using the Viromer Blue (VB) transfection reagent following the manufacturer's protocol and used after 72 h. Media was replaced with fresh RPMI 18 h prior to experiments.

### Molecular cloning, protein expression and gene-silencing {#sec4.4.7}

pMX-CMV-YFP retroviral plasmid for miRNA30E-based silencing (22-mer gene-specific targets or LacZ sequence as non-targeting control) were generated as described before ([@bib15], [@bib13]). The retroviral plasmid pMXsIP was used to express mouse Asc fused to mRFP (pMX-mASC-RFP) via the 5′LTR in the plasmid. Stable transductants were first selected with puromycin and THP1 uniformly expressing Asc-mRFP were isolated by fluorescence-activated cell sorting. The pLX-mCas11-CASP4^miR^ plasmid was generated by modifying pLentiCRISPRv2 (kind gift from Feng Zhang, Addgene \#5296; 3^rd^ generation lentiviral plasmid). mCas11 was expressed using the EFS-NS promoter, and the CASP4miR30E sequence was cloned immediately downstream. The IRE-puromycin cassette (from pMXs-IP) was cloned downstream of the Cas11-CASP4^miR^ sequence to generate the pLX-mCas11-CASP4^miR^ plasmid. These plasmids were transduced into the THP^*CASP4miR*^ line for more effective silencing of endogenous caspase-4 expression. Caspase-11^CM^ (Cys254Ala) and the Cas11^KE^ (Lys62Glu,Lys63Glu,Lys64Glu) mutation was generated by overlap-PCR. Plasmid-inserts cloned using PCR or oligonucleotides were verified by sequencing (GATC Biotech). miRNA30E sequences used in this study are listed in The [Key Resources Table](#sec4.1){ref-type="sec"}.

### Retroviral and Lentiviral transduction {#sec4.4.8}

pCMV-MMLV-Gag-Pol (for retroviral plasmids), Lentiviral packaging plasmid 1266 (for lentiviral plasmids) and pCMV-VSV-G (gifts from Pradeep Uchil and Walther Mothes, Yale University) were used as described before ([@bib13]) with some modifications. Briefly, 1 μg DNA at the ratio of 5:4:1 of plasmid-of-interest:MMLV-Gag-Pol:VSG-G was transfected into HEK293T cells using Lipofectamine 2000 (2.5 μL per 1 μg DNA in 12-well plates) for 48 h; for lentiviral transductions, a ratio of 3:2:1 was used. Virus containing supernatants were filtered through 0.45 μm low protein binding filters (Pall Life Sciences) and 300 μL were transferred on THP1 cells plated at 5 × 10^5^ cells per well in 12-well plates. Puromycin (2 μg/ml) was added 48 h after transduction and replenished until stable pools were obtained. Cells were sorted to enrich YFP+ cells as necessary on a FACS Aria III flow sorter (BD Biosciences).

### Immunofluorescence analysis {#sec4.4.9}

Cells plated on coverslips were infected as above, washed in PBS and fixed in PBS plus 4% paraformaldehyde for 15 min, washed thrice in PBS. Cells were permeabilized for 4 min in 0.2% Triton X-100, incubated in PBS plus 50 mM NH~4~Cl as a quenching agent for 10 min, washed thrice in PBS, and blocked in PBS plus 1% bovine serum albumin (BSA) for 30 min before staining with primary antibodies in 1% BSA-PBS for 45 min. Coverslips were washed twice in PBS and incubated with secondary antibodies, Phalloidin AlexaFluor647 or Phalloidin Alexa Fluor 594 and DAPI dye in 1% BSA-PBS for 30 min, washed once in PBS and once in water before being mounted in Gold Pro-Long Anti-fade medium. Epifluorescence microscopy used a Zeiss AxioImager Z1 microscope and images were processed using Fiji™ image or Zen Blue software.

### Enzyme-linked Immunosorbent Assays {#sec4.4.10}

IL-1β in culture supernatants was measured using the human IL-1β ELISA kit (R&D Systems) by following manufacturer's protocol. Samples were measured on a FLUOstar Omega microplate reader (BMG Labtech) at an absorbance of 450 nm, and absorbance at 540 nm was subtracted for well-correction.

### Antibiotic protection assays {#sec4.4.11}

Assays were performed similarly to those described before ([@bib28], [@bib56]). THP1^GSDMDmiR^ cells (7.5 × 10^4^/well) were seeded in triplicate in 96-well plates and differentiated for 48 h, after which medium without PMA or antibiotics was used. Cells were infected with various strains of EPEC at an MOI of 10 (confirmed retrospectively by plating), by centrifuging bacteria on macrophages for 10 min at 700 x*g.* Gentamicin (100 μg/ml) was added at 2 h post-infection and some wells also received chloroquine (200 μg/ml) 3 h post-infection. After an additional 1 h (i.e., 4 h post-infection), cells were washed 3 times in RPMI, lysed in 0.5% Triton X-100 for 10 min and serially diluted in sterile PBS. Dilutions were plated in triplicate on selective LB agar and colonies were enumerated. The fraction of gentamicin+chloroquine protected bacteria as percentage of total gentamicin-protected bacteria for respective wells were plotted.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Statistical Analysis {#sec4.5.1}

No statistical methods were used to determine sample size. Experiments were not randomized and investigators were allocated without blinding during experimentation and analyses. All experiments were repeated independently at least twice or as indicated in Figure Legends. For ELISA, LDH-release, PI-uptake assays and CFU experiments two to three technical replicates were used to estimate experimental mean, and biologically independent repeat experiments (indicated by *n* in Figure Legends) were carried out. MDMs from independent donors were used and sometimes independent experiments repeated on cells from the same donor on a different day with fresh cultures of bacteria, as indicated by donor number and number of experiments in Figure Legends. Means from two or more biologically independent experiments are shown in figures and were analyzed by statistical methods (indicated by *n* in Figure Legends). For immunofluorescence assays, typically ∼100-200 host cells were counted from at least 5 randomly selected fields and % cells showing events were obtained for each experiment. Mean % from n = 3-4 biologically independent experiments were compared statistically. Log-transformed (CFU experiments), logit-transformed fractions (CFU experiments) or untransformed data were found to be normally distributed (based on D'Agostino & Pearson or Shapiro Wilk normality tests), and outliers were identified using the ROUT method based on false discovery rates (FDR; Q = 5%). One-way ANOVA or paired two-tailed Student's t test were used to compare means, and if more than three comparisons were made from the same dataset, *P value*s were corrected by the Dunnett's test or the FDR approach of Benjamini, Krieger and Yekutieli (Q = 5%) as implemented in Prism (Graph Pad Software Inc., version 8.0.2). Real-time PI uptake assays from biologically independent experiments were analyzed by repeated-measures two-way ANOVA followed by FDR-based correction (Q = 5%) for indicated multiple-comparisons as implemented in Prism. Means ± SEMs are plotted unless indicated otherwise. For dot-plots, all data points are shown as symbols matched by shape and color, and the mean is indicated by a horizontal line. Data plots and statistics used Prism 8.0.2.
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